eClinical Tech News

Predictive Oncology has launched an aggressive pivot into decentralized AI infrastructure alongside reporting weak third-quarter financials. The company initiated...

Benitec Biopharma has secured FDA Fast Track designation for BB-301 and reported positive interim results from its Phase 1b/2a...

HCW Biologics reported third-quarter 2025 results and outlined near-term clinical milestones, including plans to dose the first patient in...

Verrica Pharmaceuticals reported third-quarter 2025 revenue of $14.3 million, driven by $3.6 million in Ycanth sales and $10.7 million...

Biogen has completed its acquisition of Alcyone Therapeutics, adding an implantable intrathecal drug delivery system, ThecaFlex DRx, to its...

Entera Bio secured FDA alignment that a single, 24‑month, multinational Phase 3 trial using change in total hip bone...

Inhibikase Therapeutics reported third-quarter 2025 results and set a near-term catalyst: the initiation of its Phase 2b IMPROVE-PAH study...

Tevogen Bio filed its Q3 2025 10-Q, reporting a GAAP operating loss of $5.7 million for the quarter, a...

Prelude Therapeutics outlined a 2026 clinical re-entry, built around two precision oncology assets: advancing a mutant-selective JAK2V617F JH2 allosteric...

Zenas Biopharma (Nasdaq: ZBIO) packed several catalysts into its latest update: topline data from the phase 3 Indigo trial...